Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
May 14, 2026
Reporting period
Not applicable
Filed with the SEC
May 20, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001213900-26-059558
Filed / recorded
May 20, 2026, 8:30 PM UTC
Added to OQRO
Oct 7, 2026, 5:52 AM UTC
Parser
form4-xml-v2
Data quality
Needs review
Issuer
Unicycive Therapeutics, Inc.
Issuer CIK
1766140
Ticker
UNCY
Reporting person
Pramod Gupta
Relationship
Officer
Officer title
EVP, Pharmaceuticals and BD
Security
Restricted Stock Unit
Table
Derivative (Table II)
Transaction date
May 14, 2026
Transaction code
A
Shares / units
169,500
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
169,500
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.